NCT01342757 2018-01-29Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive GlioblastomaNational Cancer Institute (NCI)Phase NA Completed12 enrolled 8 charts